Acasă › Cancer pulmonar › Missouri › Kansas City
Studii clinice pentru Cancer pulmonar în Kansas City, MO
19 studii pentru Cancer pulmonar caută participanți în și în jurul orașului Kansas City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Saint Luke's Hospital of Kansas City, Kansas City
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
În curs de recrutareFaza 3
- Kansas City Veterans Affairs Medical Center, Kansas City
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Saint Luke's Hospital of Kansas City, Kansas City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Kansas City Veterans Affairs Medical Center, Kansas City
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- University Health Truman Medical Center, Kansas City
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
În curs de recrutareFaza 1
- St. Lukes Hospital of Kansas City, Kansas City
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
În curs de recrutareFaza 3
- The University of Kansas Cancer Center, Westwood · La 5 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Saint Luke's Hospital of Kansas City, Kansas City
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
În curs de recrutareFaza 1/2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · La 5 mi distanță
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- The University of Kansas Cancer Center - Westwood, Westwood · La 5 mi distanță
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · La 5 mi distanță
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
În curs de recrutareFaza 3
- University of Kansas Cancer Center - North, Kansas City
Integrated Cancer Repository for Cancer Research
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- și încă 1
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
În curs de recrutareFaza 1/2
- The University of Kansas Cancer Center, Westwood · La 5 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- și încă 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
- și încă 2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- și încă 1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Kansas City
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
În curs de recrutareStudiu observațional
- Saint Lukes Hospital, Kansas City
Studii pentru Cancer pulmonar în alte orașe
- Houston, TX78 studii
- Boston, MA62 studii
- New York City, NY60 studii
- Los Angeles, CA45 studii
- Arlington, VA41 studii
- Washington, DC41 studii
- Chicago, IL41 studii
- Baltimore, MD40 studii
- Nashville, TN40 studii
- St. Louis, MO39 studii
- Columbus, OH37 studii
- Philadelphia, PA36 studii
Alte studii în Kansas City
- Cancer de sân34 studii
- Cancer pulmonar cu celule non-pătrate31 studii
- Insuficiență cardiacă25 studii
- Cancer (toate tipurile)21 studii
- Cancer colorectal16 studii
- Cancer metastatic15 studii
- Leucemie mieloasă acută15 studii
- Cancer de prostată14 studii
- Cancer ovarian11 studii
- Obezitate11 studii
- Diabet de tip 211 studii
- Boli cardiovasculare11 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.